Substituted piperazines as CB1 antagonists

Details for Australian Patent Application No. 2009230816 (hide)

Owner Schering Corporation

Inventors Scott, Jack D.; Stamford, Andrew W.; Weinstein, Jay; Gilbert, Eric J.; Greenlee, William J.; Miller, Michael W.

Agent Griffith Hack

Pub. Number AU-A-2009230816

Parent 2005311930

Filing date 29 October 2009

Wipo publication date 19 November 2009

International Classifications

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

19 November 2009 Application Open to Public Inspection

  Published as AU-A-2009230816

19 November 2009 Complete Application Filed

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009230817-Laser digitizer system for dental applications

2009230815-Overhead garage door with decorative house facade elements